๐Ÿงช Beta โ€” BiohacksAI is under active development. Data and features may change.
B
BiohacksAI
Evidence-Based Biohacking
BetaPatent Pending

cp vs win

Mechanistic comparison of cp 55940 and win 552122 based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

2
Shared Targets
50%
Jaccard Similarity
28%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

cp 55940
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’
win 552122
โ€”
Evidence Score
0
PubMed Studies
View full profile โ†’

Target Overlap

cp and win share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 โ‰ค 10 ยตM) and ChEMBL. A Jaccard index of 0.500 means 50% of the combined target set is bound by both compounds. The IDF-weighted score of 0.284 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do cp and win have in common?
cp and win share 2 molecular targets with a Jaccard similarity of 50%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can cp and win be combined?
cp and win share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: cp or win?
In the BiohacksAI corpus: cp has 0 PubMed-indexed studies, win has 0 studies.

Related Comparisons

Similar to cp

cp vs dronabinol4 targetscp vs sr2 targetscp vs delta2 targetscp vs ibipinabant2 targetscp vs nabilone2 targets

Similar to win

win vs taranabant2 targetswin vs rimonabant2 targetswin vs 22 targetswin vs magnolol2 targetswin vs anandamide2 targets
View full cp profile โ†’View full win profile โ†’Browse all substances โ†’